Flatt PR

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (11)

Title : Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline - Gault_2015_Diabetes.Obes.Metab_17_403
Author(s) : Gault VA , Lennox R , Flatt PR
Ref : Diabetes Obes Metab , 17 :403 , 2015
Abstract : Gault_2015_Diabetes.Obes.Metab_17_403
ESTHER : Gault_2015_Diabetes.Obes.Metab_17_403
PubMedSearch : Gault_2015_Diabetes.Obes.Metab_17_403
PubMedID: 25580570

Title : A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation - Lynch_2014_Diabetologia_57_1927
Author(s) : Lynch AM , Pathak N , Pathak V , O'Harte FP , Flatt PR , Irwin N , Gault VA
Ref : Diabetologia , 57 :1927 , 2014
Abstract : Lynch_2014_Diabetologia_57_1927
ESTHER : Lynch_2014_Diabetologia_57_1927
PubMedSearch : Lynch_2014_Diabetologia_57_1927
PubMedID: 24962667

Title : Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes - Flatt_2008_Front.Biosci_13_3648
Author(s) : Flatt PR , Bailey CJ , Green BD
Ref : Front Biosci , 13 :3648 , 2008
Abstract : Flatt_2008_Front.Biosci_13_3648
ESTHER : Flatt_2008_Front.Biosci_13_3648
PubMedSearch : Flatt_2008_Front.Biosci_13_3648
PubMedID: 18508462

Title : Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob\/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1-39)amide - Irwin_2007_Diabetes.Metab.Res.Rev_23_572
Author(s) : Irwin N , McClean PL , Cassidy RS , O'Harte F P , Green BD , Gault VA , Harriott P , Flatt PR
Ref : Diabetes Metab Res Rev , 23 :572 , 2007
Abstract : Irwin_2007_Diabetes.Metab.Res.Rev_23_572
ESTHER : Irwin_2007_Diabetes.Metab.Res.Rev_23_572
PubMedSearch : Irwin_2007_Diabetes.Metab.Res.Rev_23_572
PubMedID: 17315241

Title : Comparison of the subchronic antidiabetic effects of DPP IV-resistant GIP and GLP-1 analogues in obese diabetic (ob\/ob) mice - Irwin_2007_J.Pept.Sci_13_400
Author(s) : Irwin N , McClean PL , Flatt PR
Ref : J Pept Sci , 13 :400 , 2007
Abstract : Irwin_2007_J.Pept.Sci_13_400
ESTHER : Irwin_2007_J.Pept.Sci_13_400
PubMedSearch : Irwin_2007_J.Pept.Sci_13_400
PubMedID: 17486662

Title : Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes - Green_2006_Diab.Vasc.Dis.Res_3_159
Author(s) : Green BD , Flatt PR , Bailey CJ
Ref : Diab Vasc Dis Res , 3 :159 , 2006
Abstract : Green_2006_Diab.Vasc.Dis.Res_3_159
ESTHER : Green_2006_Diab.Vasc.Dis.Res_3_159
PubMedSearch : Green_2006_Diab.Vasc.Dis.Res_3_159
PubMedID: 17160910

Title : Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob\/ob mice - Parker_2006_J.Endocrinol_191_93
Author(s) : Parker JC , Lavery KS , Irwin N , Green BD , Greer B , Harriott P , O'Harte FP , Gault VA , Flatt PR
Ref : J Endocrinol , 191 :93 , 2006
Abstract : Parker_2006_J.Endocrinol_191_93
ESTHER : Parker_2006_J.Endocrinol_191_93
PubMedSearch : Parker_2006_J.Endocrinol_191_93
PubMedID: 17065392

Title : Inhibition of dipeptidylpeptidase IV activity as a therapy of type 2 diabetes - Green_2006_Expert.Opin.Emerg.Drugs_11_525
Author(s) : Green BD , Flatt PR , Bailey CJ
Ref : Expert Opin Emerg Drugs , 11 :525 , 2006
Abstract : Green_2006_Expert.Opin.Emerg.Drugs_11_525
ESTHER : Green_2006_Expert.Opin.Emerg.Drugs_11_525
PubMedSearch : Green_2006_Expert.Opin.Emerg.Drugs_11_525
PubMedID: 16939389

Title : Pituitary adenylate cyclase-activating peptide (PACAP): assessment of dipeptidyl peptidase IV degradation, insulin-releasing activity and antidiabetic potential - Green_2006_Peptides_27_1349
Author(s) : Green BD , Irwin N , Flatt PR
Ref : Peptides , 27 :1349 , 2006
Abstract : Green_2006_Peptides_27_1349
ESTHER : Green_2006_Peptides_27_1349
PubMedSearch : Green_2006_Peptides_27_1349
PubMedID: 16406202

Title : Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes - Lindsay_2005_Diabet.Med_22_654
Author(s) : Lindsay JR , Duffy NA , McKillop AM , Ardill J , O'Harte FP , Flatt PR , Bell PM
Ref : Diabet Med , 22 :654 , 2005
Abstract : Lindsay_2005_Diabet.Med_22_654
ESTHER : Lindsay_2005_Diabet.Med_22_654
PubMedSearch : Lindsay_2005_Diabet.Med_22_654
PubMedID: 15842525

Title : A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide - Green_2005_Diabetes.Obes.Metab_7_595
Author(s) : Green BD , Gault VA , O'Harte FP , Flatt PR
Ref : Diabetes Obes Metab , 7 :595 , 2005
Abstract : Green_2005_Diabetes.Obes.Metab_7_595
ESTHER : Green_2005_Diabetes.Obes.Metab_7_595
PubMedSearch : Green_2005_Diabetes.Obes.Metab_7_595
PubMedID: 16050953